Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis

被引:1
|
作者
Grani, Giorgio [1 ]
D'Elia, Silvia [2 ]
Puxeddu, Efisio [3 ]
Morelli, Silvia
Arvat, Emanuela [4 ]
Nervo, Alice [4 ]
Spiazzi, Giovanna [5 ]
Rolli, Nicoletta [5 ]
Zatelli, Maria Chiara [6 ]
Ambrosio, Maria Rosaria [6 ]
Ceresini, Graziano [7 ]
Marina, Michela [7 ]
Mele, Chiara [8 ]
Aimaretti, Gianluca [8 ]
Santaguida, Maria Giulia [9 ]
Virili, Camilla [9 ]
Crescenzi, Anna [10 ,11 ]
Palermo, Andrea [12 ]
Rossetto Giaccherino, Ruth [13 ]
Meomartino, Letizia [13 ]
Castagna, Maria Grazia [14 ]
Maino, Fabio [14 ]
Trevisan, Matteo [15 ]
De Leo, Simone [15 ]
Chiofalo, Maria Grazia [16 ]
Pezzullo, Luciano
Sparano, Clotilde [17 ]
Petrone, Luisa [17 ]
Di Dalmazi, Giulia [18 ]
Napolitano, Giorgio [18 ]
Tumino, Dario [19 ]
Crocetti, Umberto [20 ]
Bertagna, Francesco [21 ,22 ]
Deandrea, Maurilio [23 ]
Antonelli, Alessandro [24 ]
Mian, Caterina [25 ]
Carbone, Antonella [26 ]
Monti, Salvatore [27 ]
Porcelli, Tommaso [28 ]
Brigante, Giulia [29 ,30 ]
Barbaro, Daniele [31 ]
Alfo, Marco [2 ]
Ferraro Petrillo, Umberto [2 ]
Filetti, Sebastiano [1 ]
Durante, Cosimo [1 ]
机构
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Viale Policlin 155, I-00161 Rome, Italy
[2] Sapienza Univ Rome, Dept Stat Sci, I-00185 Rome, Italy
[3] Univ Perugia, Dept Med & Surg, I-06129 Perugia, Italy
[4] Univ Turin, Citta Salute & Sci Hosp, Dept Med Sci, Oncol Endocrinol Unit, I-10126 Turin, Italy
[5] Azienda Osped Univ Verona, Dept Med, Endocrinol & Diabetol Unit, I-37126 Verona, Italy
[6] Univ Ferrara, Dept Med Sci, Sect Endocrinol Geriatr & Internal Med, I-44121 Ferrara, Italy
[7] Univ Hosp Parma, Unit Internal Med & Oncol Endocrinol, I-43126 Parma, Italy
[8] Univ Piemonte Orientale, Dept Translat Med, Endocrinol, I-28100 Novara, Italy
[9] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Endocrinol Unit, I-04100 Latina, Italy
[10] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, I-00161 Rome, Italy
[11] Fdn Policlin Univ Campus Biomed, Unit Endocrine Organs & Neuromuscolar Pathol, I-00128 Rome, Italy
[12] Fdn Policlin Univ Campus Biomed, Unit Metab Bone & Thyroid Dis, Rome, Italy
[13] Univ Turin, Dept Med Sci, Endocrinol Diabetol & Metab, I-10126 Turin, Italy
[14] Univ Siena, Dept Med Surg & Neurosci, Sect Endocrinol, I-53100 Siena, Italy
[15] IRCCS Ist Auxol Italiano, Dept Endocrine & Metab Dis, Endocrine Oncol Unit, I-20095 Milan, Italy
[16] NCI, IRCCS Fdn G Pascale, I-80131 Naples, Italy
[17] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Endocrinol Unit, I-50134 Florence, Italy
[18] Univ G Annunzio Chieti Pescara, Dept Med & Aging Sci, I-66100 Chieti, Italy
[19] Univ Catania, Dept Clin & Expt Med, I-95122 Catania, Italy
[20] IRCCS, Dept Med Sci, Hosp Casa Sollievo Sofferenza, I-71013 San Giovanni Rotondo, Italy
[21] Univ Brescia, Dept Med & Surg Specialties, Nucl Med, Radiol Sci, I-25123 Brescia, Italy
[22] Spedali Civili Brescia, I-25123 Brescia, Italy
[23] AO Ordine Mauriziano Torino, UO Endocrinol Diabetol & Malattie Metab, I-10128 Turin, Italy
[24] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Area, I-56100 Pisa, Italy
[25] DIMED Univ Padua, Dept Med, Operat Unit Endocrinol, I-35128 Padua, Italy
[26] Tinchi Hosp, Endocrine Unit, Matera, Italy
[27] Sapienza Univ Rome, Endocrinol & Diabet Unit, Azienda Osped Univ Sant Andrea, I-00189 Rome, Italy
[28] Univ Naples Federico II, Dept Publ Hlth, I-80131 Naples, Italy
[29] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Unit Endocrinol, I-41125 Modena, Italy
[30] Azienda Osped Univ Modena, Dept Med Specialties, Unit Endocrinol, I-41124 Modena, Italy
[31] Unit Endocrinol ASL North West Tuscany, Ospedali Riuniti, I-57124 Livorno, Italy
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2024年
关键词
thyroglobulin; threshold; predictor; treatment response; radioiodine; RADIOIODINE REMNANT ABLATION; SERUM THYROGLOBULIN; RADIOACTIVE IODINE; CLINICAL-PRACTICE; SELECTIVE USE; PAPILLARY; AUTOANTIBODY; GUIDELINES; MANAGEMENT; ASSAYS;
D O I
10.1210/clinem/dgae559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The utility of thyroglobulin (Tg) in the follow-up of patients with differentiated thyroid cancer has been well-documented. Although third-generation immunoassays have improved accuracy, limitations persist (interfering anti-Tg antibodies and measurement variability). Evolving treatment strategies require a reevaluation of Tg thresholds for optimal patient management.Objective To assess the performance of serum Tg testing in 2 populations: patients receiving total thyroidectomy and radioiodine remnant ablation (RRA) or treated with thyroidectomy alone.Design Prospective observational study.Setting Centers contributing to the Italian Thyroid Cancer Observatory database.Patients We included 540 patients with 5 years of follow-up and negative anti-Tg antibodies.Interventions Serum Tg levels assessed at 1-year follow-up visit.Main Outcome Measure Detection of structural disease within 5 years of follow-up.Results After excluding 26 patients with structural disease detected at any time point, the median Tg did not differ between patients treated with or without radioiodine. Data-driven Tg thresholds were established based on the 97th percentile of Tg levels in disease-free individuals: 1.97 ng/mL for patients undergoing thyroidectomy alone (lower than proposed by the Memorial Sloan Kettering Cancer Center protocol and ESMO Guidelines, yet demonstrating good predictive ability, with a negative predictive value of 98% and 0.84 ng/mL for patients receiving postsurgical RRA. High sensitivity and negative predictive value supported the potential of these thresholds in excluding structural disease.Conclusion This real-world study provides evidence for the continued reliability of 1-year serum Tg levels. The data-driven Tg thresholds proposed offer valuable insights for clinical decision-making in patients undergoing total thyroidectomy with or without RRA.
引用
收藏
页数:8
相关论文
共 47 条
  • [41] RECURRENCE AND CANCER-SPECIFIC MORTALITY DURING FOLLOW-UP OF ENDOSCOPICALLY RESECTED LOW- AND HIGH-RISK PT1 COLORECTAL CANCERS: A META-ANALYSIS
    Antonelli, Giulio
    Vanella, Giuseppe
    Orlando, Davide
    Angeletti, Stefano
    Di Giulio, Emilio
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB383 - AB384
  • [42] Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
    Hidetoshi Kawaguchi
    Norikazu Masuda
    Takahiro Nakayama
    Kenjiro Aogi
    Keisei Anan
    Yoshinori Ito
    Shoichiro Ohtani
    Nobuaki Sato
    Shigehira Saji
    Toshimi Takano
    Eriko Tokunaga
    Seigo Nakamura
    Yoshie Hasegawa
    Masaya Hattori
    Tomomi Fujisawa
    Satoshi Morita
    Miki Yamaguchi
    Hiroko Yamashita
    Toshinari Yamashita
    Yutaka Yamamoto
    Daisuke Yotsumoto
    Masakazu Toi
    Shinji Ohno
    Breast Cancer, 2020, 27 : 389 - 398
  • [43] Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
    Kawaguchi, Hidetoshi
    Masuda, Norikazu
    Nakayama, Takahiro
    Aogi, Kenjiro
    Anan, Keisei
    Ito, Yoshinori
    Ohtani, Shoichiro
    Sato, Nobuaki
    Saji, Shigehira
    Takano, Toshimi
    Tokunaga, Eriko
    Nakamura, Seigo
    Hasegawa, Yoshie
    Hattori, Masaya
    Fujisawa, Tomomi
    Morita, Satoshi
    Yamaguchi, Miki
    Yamashita, Hiroko
    Yamashita, Toshinari
    Yamamoto, Yutaka
    Yotsumoto, Daisuke
    Toi, Masakazu
    Ohno, Shinji
    BREAST CANCER, 2020, 27 (03) : 389 - 398
  • [44] Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 Years
    Bal, Chandrasekhar
    Satapathy, Swayamjeet
    Tupalli, Avinash
    Ballal, Sanjana
    THYROID, 2022, 32 (10) : 1220 - 1228
  • [45] Providing evidence from real-world data - three-year follow-up of dolutegravir-based regimens in routine clinical care in Germany: the final analysis of the DOL-ART cohort
    Postel, N.
    Wyen, C.
    Hillenbrand, H.
    Lutz, T.
    Moll, A.
    Pauli, R.
    Sych, M.
    Westermayer, B.
    Lueftenegger, D.
    Walli, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [46] Two years follow-up data of multiple-line treatment in stage IV tumors from a whole exome-guided real-world study of 1,000 Chinese cancer patients.
    Xu, Qiang
    Chen, Cheng
    Pei, Xiaoyu
    Liu, Xiuli
    Xu, Xiaoman
    Wang, Guan
    Cai, Xin
    Wei, Jinwang
    Wu, Angela
    Dai, Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Real-World Data (RWD) on the 3-Year Follow-Up Outcomes of Different CNS Prophylaxis Strategies Across CNS-IPI Risk Groups in Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
    Faqah, Anadil
    Asif, Summaiya
    Goksu, Suleyman Yasin
    Sheikh, Hassan S.
    JCO GLOBAL ONCOLOGY, 2021, 7 : 486 - 494